---
figid: PMC5402913__dddt-11-1221Fig2
figlink: /pmc/articles/PMC5402913/figure/f2-dddt-11-1221/
number: F2
caption: 'Mechanism of action of romosozumab.Notes: Romosozumab is a human monoclonal
  antibody that binds sclerostin (an inhibitor of Wnt pathway signaling). When this
  monoclonal antibody binds to sclerostin, sclerostin cannot bind to the LRP-5 and
  LRP-6 receptors and is unable to exert its inhibitory effect. Wnt binds to LRP-5
  or LRP-6 coreceptors and specific Frizzled family receptor, leading to activation
  of the Wnt signaling pathway and bone formation. Copyright ©2015. Dove Medical Press.
  Shah AD, Shoback D, Lewiecki EM. Sclerostin inhibition: a novel therapeutic approach
  in the treatment of osteoporosis. Int J Womens Health. 2015;7:565–580.Abbreviation:
  LRP, LDL-receptor-related protein.'
pmcid: PMC5402913
papertitle: Profile of romosozumab and its potential in the management of osteoporosis.
reftext: Sian Yik Lim, et al. Drug Des Devel Ther. 2017;11:1221-1231.
pmc_ranked_result_index: '82602'
pathway_score: 0.9576251
filename: dddt-11-1221Fig2.jpg
figtitle: 'Mechanism of action of romosozumab.Notes: Romosozumab is a human monoclonal
  antibody that binds sclerostin (an inhibitor of Wnt pathway signaling)'
year: '2017'
organisms:
- Homo sapiens
ndex: 95462a6d-dee2-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5402913__dddt-11-1221Fig2.html
  '@type': Dataset
  description: 'Mechanism of action of romosozumab.Notes: Romosozumab is a human monoclonal
    antibody that binds sclerostin (an inhibitor of Wnt pathway signaling). When this
    monoclonal antibody binds to sclerostin, sclerostin cannot bind to the LRP-5 and
    LRP-6 receptors and is unable to exert its inhibitory effect. Wnt binds to LRP-5
    or LRP-6 coreceptors and specific Frizzled family receptor, leading to activation
    of the Wnt signaling pathway and bone formation. Copyright ©2015. Dove Medical
    Press. Shah AD, Shoback D, Lewiecki EM. Sclerostin inhibition: a novel therapeutic
    approach in the treatment of osteoporosis. Int J Womens Health. 2015;7:565–580.Abbreviation:
    LRP, LDL-receptor-related protein.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FZD2
  - FZD5
  - FZD7
  - WNT1
  - WNT2
  - FZD10
  - CTNNB1
  - WNT9A
  - WNT9B
  - WNT3
  - FZD3
  - WNT5B
  - WNT3A
  - FZD1
  - WNT10A
  - FZD6
  - FZD8
  - WNT4
  - FZD4
  - AXIN2
  - WNT16
  - WNT7B
  - WNT5A
  - WNT6
  - WNT7A
  - WNT2B
  - FZD9
  - AXIN1
  - LRP6
  - WNT11
  - WNT8A
  - WNT10B
  - WNT8B
genes:
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD2
  entrez: '2535'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD5
  entrez: '7855'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD7
  entrez: '8324'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT1
  entrez: '7471'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2
  entrez: '7472'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD10
  entrez: '11211'
- word: B-catenin
  symbol: beta-catenin
  source: hgnc_alias_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9A
  entrez: '7483'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9B
  entrez: '7484'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3
  entrez: '7473'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD3
  entrez: '7976'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5B
  entrez: '81029'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3A
  entrez: '89780'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD1
  entrez: '8321'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10A
  entrez: '80326'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD6
  entrez: '8323'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD8
  entrez: '8325'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT4
  entrez: '54361'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD4
  entrez: '8322'
- word: Axin
  symbol: AXIN
  source: bioentities_symbol
  hgnc_symbol: AXIN2
  entrez: '8313'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT16
  entrez: '51384'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7B
  entrez: '7477'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5A
  entrez: '7474'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT6
  entrez: '7475'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7A
  entrez: '7476'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2B
  entrez: '7482'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD9
  entrez: '8326'
- word: Axin
  symbol: AXIN
  source: bioentities_symbol
  hgnc_symbol: AXIN1
  entrez: '8312'
- word: LRP-5/6
  symbol: LRP6
  source: hgnc_symbol
  hgnc_symbol: LRP6
  entrez: '4040'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT11
  entrez: '7481'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8A
  entrez: '7478'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10B
  entrez: '7480'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8B
  entrez: '7479'
chemicals: []
diseases: []
figid_alias: PMC5402913__F2
redirect_from: /figures/PMC5402913__F2
figtype: Figure
---
